GSK case study

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/25

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

26 Terms

1
New cards
Where is GSK headquartered?
The UK.
2
New cards
What was GSK’s turnover and profit in 2019?
£34 billion turnover, £7 billion operating profit.
3
New cards
How many medicine packs did GSK produce in 2019?
2.3 billion packs.
4
New cards
How many vaccine doses did GSK produce in 2019?
701 million doses.
5
New cards
What proportion of GSK's revenue comes from pharmaceuticals?
Two-thirds (2/3).
6
New cards
In how many countries does GSK operate manufacturing sites?
36 countries.
7
New cards
How many employees does GSK have globally?
Over 100,000.
8
New cards
Where are GSK's R&D centres located?
UK, USA, Spain, Belgium, China.
9
New cards
What is the scale of GSK's R&D investment?
£4.6 billion annually; employs 15,000 people in R&D.
10
New cards
What diseases are GSK currently researching as WHO priorities?
HIV/AIDS, Malaria, and Tuberculosis (TB).
11
New cards
Name three well-known GSK medications on the WHO essential list.
Amoxicillin, Zidovudine, Bendazole.
12
New cards
Why is drug development expensive and risky for GSK?
It takes ~10 years and $2.6 billion; many drugs fail during development.
13
New cards
Why is demand for new drugs weak in LIDCs?
Low purchasing power; sales often don't cover R&D costs.
14
New cards
What ethical policies has GSK adopted for developing countries?
Capped prices at 25% of UK level, 5% return, HIV drug discounts, generic licenses, reinvesting 20% profits.
15
New cards
What percentage return does GSK aim for in LICs?
5% return per product.
16
New cards
What initiative does GSK support to make drugs affordable in LICs?
Licensing for cheap generics and significant HIV/AIDS drug discounts.
17
New cards
What global health impact is GSK aiming to make with vaccines?
Developing effective vaccines for Malaria and Ebola.
18
New cards
What are some criticisms of pharmaceutical companies like GSK?
Excessive profits, high drug prices, lobbying, neglect of unprofitable diseases.
19
New cards
What type of drugs do pharmaceutical companies prioritize and why?
Long-term prescription drugs like opioids and antidepressants due to profitability.
20
New cards
What diseases have been historically neglected by pharma companies?
Forgotten tropical diseases and antibiotic-resistant infections.
21
New cards
Why are patents important in the pharmaceutical industry?
They protect investment, prevent market failure, and fund R&D.
22
New cards
How long do drug patents typically last?
20 years.
23
New cards
What negative effect can patents have in healthcare?
Market monopoly, high prices, limited access for the poor.
24
New cards
What is the estimated cost and time to develop a new prescription drug?
~$2.6 billion and around 10 years.
25
New cards
What would happen without patent protection in pharmaceuticals?
Reduced R&D investment; competitors undercut original inventors.
26
New cards
What are GSK’s contributions to tropical disease research?
Research centre in Spain focused on TB and malaria.